Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

株式のランク #449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
株価
$763.31
時価総額
$53.31B
変化(1日)
0.87%
変化(1年)
8.49%
国
CH
取引 Lonza Group AG (LONN)

カテゴリー

Healthcare
Lonza Group AG(LONN)のP/S比率
2026 時点のP/S比率 TTM: 0
Lonza Group AG の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Lonza Group AG の P/S 比率の履歴(2004 ~ 2026)
各年末時点のP/S比率
年 P/S比率 変化
2025 5.77 -0.67%
2024 5.80 49.68%
2023 3.88 -28.25%
2022 5.40 -48.31%
2021 10.46 11.37%
2020 9.39 50.88%
2019 6.22 81.59%
2018 3.43 -12.81%
2017 3.93 88.09%
2016 2.09 -0.13%
2015 2.09 40.40%
2014 1.49 30.83%
2013 1.14 70.33%
2012 0.67 -37.18%
2011 1.06 -27.38%
2010 1.47 6.38%
2009 1.38 -21.31%
2008 1.75 -30.69%
2007 2.53 0.33%
2006 2.52 66.67%
2005 1.51 8.72%
2004 1.39 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
10.02 -
US
40.55 -
US
4.19 -
AU
10.44 -
NL
4.52 -
BE